Our history

Our history

1997

Foundation

First EU GMP artesunate: Arinate®

Arinate group

First β-Artemether: Artemether® 80mg/ml

Artemether
2000

First EU GMP pediatric suspension: Artesiane®

Artesiane
2002

First artemisinin-based combination therapy marketed: Ariplus®

Ariplus
2003

First Co-Arinate® co-blister

Co-Arinate co-blister
2004

First artemisinin-based combination therapy paediatric suspension: Co-Artesiane®

Co-Artesiane
2005

Move to our current headquarters in Turnhout

Belgian headoffice
2006

First FDC marketed: Co-Arinate®

Co-Arinate
2008

Start portfolio diversification program

2009

Dafra Pharma Swiss subsidiary for warehousing and logistics

2011

100 sales representatives in Africa

2013

Passing away of founder / R&D director / president Dr. Frans Herwig Jansen

Dr. Jansen
2014

Introduction CRM system African sales force

2017

20 years Dafra Pharma

175 sales representatives in Africa

present

Well-balanced product portfolio

Dafra portfolio